As of 2025-07-01, the Intrinsic Value of Rapt Therapeutics Inc (RAPT) is -39.85 USD. This RAPT valuation is based on the model Peter Lynch Fair Value. With the current market price of 8.00 USD, the upside of Rapt Therapeutics Inc is -598.11%.
Based on its market price of 8.00 USD and our intrinsic valuation, Rapt Therapeutics Inc (RAPT) is overvalued by 598.11%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -39.85 - -39.85 | -39.85 | -598.11% |
| P/E | (78.90) - (140.91) | (102.41) | -1380.2% |
| DDM - Stable | (52.04) - (143.25) | (97.64) | -1320.6% |
| DDM - Multi | (34.47) - (76.25) | (47.75) | -696.9% |
| Market Cap (mil) | 116.44 |
| Beta | 1.54 |
| Outstanding shares (mil) | 14.55 |
| Enterprise Value (mil) | 116.44 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.86% |
| Cost of Debt | 5.00% |
| WACC | 7.77% |